%0 Journal Article
%T Multi-arm Cost-Effectiveness Analysis (CEA) comparing different durations of adjuvant trastuzumab in early breast cancer, from the English NHS payer perspective
%A Caroline S. Clarke
%A Ian Shemilt
%A Rachael M. Hunter
%A Victoria Serra-Sastre
%J Archive of "PLoS ONE".
%D 2017
%R 10.1371/journal.pone.0172731
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5383006/